These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30924375)

  • 1. Anti-inflammatory role of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) in nephroprotection.
    Afjal MA; Abdi SH; Sharma S; Ahmad S; Fatima M; Dabeer S; Akhter J; Raisuddin S
    Hum Exp Toxicol; 2019 Jun; 38(6):713-723. PubMed ID: 30924375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tempol (4-hydroxy tempo) protects mice from cisplatin-induced acute kidney injury
    Afjal MA; Goswami P; Ahmad S; Dabeer S; Akhter J; Salman M; Mangla A; Raisuddin S
    Drug Chem Toxicol; 2022 May; 45(3):1355-1363. PubMed ID: 33078650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury.
    Abouzied MM; Eltahir HM; Taye A; Abdelrahman MS
    Mol Cell Biochem; 2016 Jan; 411(1-2):107-15. PubMed ID: 26441060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tempol, a superoxide dismutase mimetic agent, reduces cisplatin-induced nephrotoxicity in rats.
    Ewees MG; Messiha BAS; Abdel-Bakky MS; Bayoumi AMA; Abo-Saif AA
    Drug Chem Toxicol; 2019 Nov; 42(6):657-664. PubMed ID: 30067109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of Cisplatin-induced renal dysfunction by Schisandra chinensis stems via anti-inflammation and anti-apoptosis effects.
    Li YZ; Ren S; Yan XT; Li HP; Li W; Zheng B; Wang Z; Liu YY
    J Ethnopharmacol; 2018 May; 217():228-237. PubMed ID: 29421595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Caputi AP; Thiemermann C
    Free Radic Res; 2004 Aug; 38(8):813-9. PubMed ID: 15493454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pathways driving the experimental hepatoprotective action of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) against acute hepatotoxicity.
    Abdel-Hamid NM; Wahid A; Mohamed EM; Abdel-Aziz MA; Mohafez OM; Bakar S
    Biomed Pharmacother; 2016 Apr; 79():215-21. PubMed ID: 27044831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.
    Ueki M; Ueno M; Morishita J; Maekawa N
    J Biosci Bioeng; 2013 May; 115(5):547-51. PubMed ID: 23245727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
    Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
    Soni H; Kaminski D; Gangaraju R; Adebiyi A
    Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
    Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
    Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morin hydrate ameliorates cisplatin-induced ER stress, inflammation and autophagy in HEK-293 cells and mice kidney via PARP-1 regulation.
    Singh MP; Chauhan AK; Kang SC
    Int Immunopharmacol; 2018 Mar; 56():156-167. PubMed ID: 29414646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].
    Ye S; Zeng S; Huang M; Chen J; Chen X; Xu P; Wang Q; Gao W; Yang B; Hao B; Huang W; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):883-890. PubMed ID: 31511206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
    Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade.
    Tomar A; Vasisth S; Khan SI; Malik S; Nag TC; Arya DS; Bhatia J
    Phytomedicine; 2017 Oct; 34():154-161. PubMed ID: 28899498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.
    Huang YC; Tsai MS; Hsieh PC; Shih JH; Wang TS; Wang YC; Lin TH; Wang SH
    Toxicol Appl Pharmacol; 2017 Aug; 329():128-139. PubMed ID: 28558962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
    Fahmi AN; Shehatou GS; Shebl AM; Salem HA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.